Important update regarding our research funding:
It goes without saying that COVID-19 is impacting the world far more than any of us could have imagined. As a charity, we are facing continued challenges in our ability to fundraise, as well as deliver the services and progress for people affected by breast cancer that we had planned. Therefore, we are looking at how we can find new ways to deliver our vital services and information and how we can make up for lost time in the labs which we have had to close during the pandemic.
We want to ensure that we are in the best possible shape to meet the challenge of supporting the people who need us most during this coronavirus crisis, and that, once the pandemic is over, we can move at pace to continue our vital work.
As the crisis has continued to evolve, our planning for all scenarios has led us to forecast that we will see a drop of nearly 35% in our total income over the next twelve months. Sadly, the reality is that we will not have the level of funding required to invest in all the things that we had hoped and planned for in 2020/21.
As a result, we have taken the difficult decision to cancel the project grant and PhD studentship grant funding rounds that were planned for 2020. As we move into our next financial year, we will keep our website updated with dates for new grant rounds. If you wish to be added to our mailing list where you will also be notified of new funding opportunities, please contact us at email@example.com.
Information about funding
Our project grants are for established researchers in the UK or Ireland who have a strong track record in their field, and who want to work in one of our priority areas.
Our PhD studentships are for established researchers in the UK and Ireland who have a strong track record in their field, and have previous experience in supervising PhD students.
We have established a funding initiative called the Breast Cancer Now Catalyst Programme with Pfizer. The next round for applications to these grants will open on 2 November 2020.